Durability of the response to peginterferon-α2b and ribavirin in patients with chronic hepatitis C: a cohort study in the routine clinical setting.

MLA

Giordanino, Chiara, et al. “Durability of the Response to Peginterferon-Α2b and Ribavirin in Patients with Chronic Hepatitis C: A Cohort Study in the Routine Clinical Setting.” European Journal of Gastroenterology & Hepatology, vol. 26, no. 1, Jan. 2014, pp. 52–58. EBSCOhost, https://doi.org/10.1097/MEG.0b013e328362dc99.

APA

Giordanino, C., Sacco, M., Ceretto, S., Smedile, A., Ciancio, A., Cariti, G., De Blasi, T., Picciotto, A., Marenco, S., Grasso, A., Pirisi, M., Smirne, C., Colletta, C., Traverso, A., Mazzucco, D., Ciccone, G., Simondi, D., Rizzetto, M., & Saracco, G. (2014). Durability of the response to peginterferon-α2b and ribavirin in patients with chronic hepatitis C: a cohort study in the routine clinical setting. European Journal of Gastroenterology & Hepatology, 26(1), 52–58. https://doi.org/10.1097/MEG.0b013e328362dc99

Chicago

Giordanino, Chiara, Marco Sacco, Simone Ceretto, Antonina Smedile, Alessia Ciancio, Giuseppe Cariti, Tiziano De Blasi, et al. 2014. “Durability of the Response to Peginterferon-Α2b and Ribavirin in Patients with Chronic Hepatitis C: A Cohort Study in the Routine Clinical Setting.” European Journal of Gastroenterology & Hepatology 26 (1): 52–58. doi:10.1097/MEG.0b013e328362dc99.